Zymeworks Inc（ZYME）の株価予測ZYMEZymeworks Inc

Alphio's ZYME stock price prediction model matches the current Zymeworks Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $25.12 (-10.98%). The 1-week path is $25.08 (-11.12%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Zymeworks Inc is a good buy right now due to its current price of $28.22, which is significantly below the average analyst price target of $39, suggesting an upside potential of approximately 38%. Additionally, the stock's RSI is at 71.216, indicating strong momentum, while the recent acquisition of Theravance Biopharma is expected to enhance revenue streams, with projected revenue for 2026 estimated between $278 million and $292 million. However, a key risk is the company's negative net income of -$44,162,000 in Q1 2026, which highlights ongoing financial challenges that investors should monitor closely.

Zymeworks Inc (ZYME) last closed at $28.22, losing -0.77%. These facts feed the 1-day and 1-week ZYME price prediction above.